In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Nanobiotix ADR (NASDAQ: NBTX) closed at $20.38 down -4.00% from its previous closing price of $21.23. In other words, the price has decreased by -$4.00 from its previous closing price. On the day, 0.16 million shares were traded. NBTX stock price reached its highest trading level at $20.54 during the session, while it also had its lowest trading level at $19.14.
Ratios:
For a deeper understanding of Nanobiotix ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63.
Upgrades & Downgrades
In the most recent recommendation for this company, Guggenheim on August 28, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On December 08, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $11.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBTX now has a Market Capitalization of 982628864 and an Enterprise Value of 1005034560. Its current Enterprise Value per Revenue stands at 98.93 whereas that against EBITDA is -22.923.
Stock Price History:
The Beta on a monthly basis for NBTX is 0.71, which has changed by 5.5727553 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, NBTX has reached a high of $30.35, while it has fallen to a 52-week low of $2.76. The 50-Day Moving Average of the stock is -0.86%, while the 200-Day Moving Average is calculated to be 127.57%.
Shares Statistics:
For the past three months, NBTX has traded an average of 93.44K shares per day and 52570 over the past ten days. A total of 48.21M shares are outstanding, with a floating share count of 38.00M. Insiders hold about 20.70% of the company’s shares, while institutions hold 0.04% stake in the company. Shares short for NBTX as of 1763078400 were 52949 with a Short Ratio of 0.57, compared to 1760486400 on 29058. Therefore, it implies a Short% of Shares Outstanding of 52949 and a Short% of Float of 0.15.
Earnings Estimates
Analysts are recommending an EPS of between -$0.29 and -$0.64 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is $0.38, with 3.0 analysts recommending between $2.01 and -$0.62.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for NBTX’s current fiscal year. The highest revenue estimate was $92.93M, while the lowest revenue estimate was $22.8M, resulting in an average revenue estimate of $44.73M. In the same quarter a year ago, actual revenue was -$7.19MBased on 5 analysts’ estimates, the company’s revenue will be $79.83M in the next fiscal year. The high estimate is $170.3M and the low estimate is $15M.
